Sign in

NCT03227419CompletedPhase 4

ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TARGETED TREATMENT INADEQUATE RESPONDER PATIENTS: A RANDOMIZED, OPENLABELED, SUPERIORITY TRIAL. -SUNSTAR-

Source: EU CTIS (euclinicaltrials.eu) · Last updated 31 Jul 2024

Brief summary (registry, in English)

Compare tocilizumab versus abatacep administered subcutaneously efficacy in inadequate responder patients to one or two targeted treaments.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
224 (actual)
First submitted
10 Jul 2024
Start date
23 Jan 2018
Lead sponsor
Groupement Des Hopitaux De L'Institut Catholique De Lille
NCT number
NCT03227419
EU CT number
2024-515600-39-00
EudraCT number
2017-000947-41

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 224
  • 27 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • counter-indication for one or other of the two drugs under study
  • Patient receiving a cortisteroid therapy over 15mg/day prednison equivalent for more than 4 weeks
  • Prior treatment by tocilizumab, sarilumab or abatacept
  • Prior treatments accepted are TNF alpha inhibitor, rituximab and jak inhibitors

Other illness

  • failure to a first or second line of targeted treatment

Other

  • breastfeeding woman

Who the study is looking for

  • age >18 years
  • RA according to the ACR/EULAR 2010 criteria
  • inadequate response to a administered first-line or second line of targeted treatment defined as moderate to high disease activity (DAS28- ESR>3.2 and CDAI>10) after at least 3 months of treatment
  • beneficiary of the French National Health Insurance Fund
  • signed informed consent form
  • for women of childbearing age: effective contraception during treatment period with engagement to continue such contraception for 14 weeks after last administration

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (27)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Avicenne
Coordinator of this site? Confirm its status
BobignyFranceCompleted
Centre hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
BordeauxFranceCompleted
Centre Hospitalier de Boulogne-Sur-Mer
Coordinator of this site? Confirm its status
Boulogne-sur-MerFranceCompleted
Centre Hospitalier Jean Rougier
Coordinator of this site? Confirm its status
CahorsFranceCompleted
Clinique De L'infirmerie Protestante De Lyon
Coordinator of this site? Confirm its status
Caluire-et-CuireFranceCompleted
Hôpital NOVO - Site de Pontoise
Coordinator of this site? Confirm its status
Cergy PontoiseFranceCompleted
CHRU de Tours - Hôpital Trousseau
Coordinator of this site? Confirm its status
Chambray-lès-ToursFranceCompleted
CHU Clermont Ferrand -Site Gabriel Montpied
Coordinator of this site? Confirm its status
Clermont-FerrandFranceCompleted
Centre Hospitalier Universitaire Grenoble Alpes
Coordinator of this site? Confirm its status
Grenoble Cedex 9FranceCompleted
CHD Vendée
Coordinator of this site? Confirm its status
La Roche-sur-YonFranceCompleted
Hôpital Bicêtre APHP
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceCompleted
CHU De Lille, Hôpital Roger Salengro
Coordinator of this site? Confirm its status
LilleFranceCompleted
Groupement Des Hopitaux De L'Institut Catholique De Lille
Coordinator of this site? Confirm its status
Lomme CedexFranceCompleted
Centre Hospitalier Universitaire De Montpellier
Coordinator of this site? Confirm its status
Montpellier Cedex 5FranceCompleted
Centre Hospitalier Universitaire de Nice
Coordinator of this site? Confirm its status
NiceFranceCompleted
Centre Hospitalier Universitaire d'Orléans
Coordinator of this site? Confirm its status
ORLEANSFranceCompleted
Hôpital Lariboisière APHP
Coordinator of this site? Confirm its status
ParisFranceCompleted
Hopital Bichat - Claude Bernard - AP-HP
Coordinator of this site? Confirm its status
ParisFranceCompleted
Assistance Publique Hopitaux de Paris – Hopital Cochin
Coordinator of this site? Confirm its status
ParisFranceCompleted
APHP - Hôpital Universitaire Pitié-Salpêtrière
Coordinator of this site? Confirm its status
PARISFranceCompleted
CHU de Poitiers
Coordinator of this site? Confirm its status
PoitiersFranceCompleted
CHU Reims Hôpital Maison Blanche
Coordinator of this site? Confirm its status
ReimsFranceCompleted
CHU de Rouen - Hôpital de Bois Guillaume
Coordinator of this site? Confirm its status
ROUENFranceCompleted
Chu de Saint Etienne
Coordinator of this site? Confirm its status
Saint-Priest-en-JarezFranceCompleted
Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg
Coordinator of this site? Confirm its status
StrasbourgFranceCompleted
Centre Hospitalier de Valenciennes
Coordinator of this site? Confirm its status
ValenciennesFranceCompleted
CHRU de Nancy - Hôpitaux de Brabois
Coordinator of this site? Confirm its status
Vandoeuvre-les-NancyFranceCompleted

This page is information, not medical advice. Discuss any trial with your doctor.